Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients

Although α-glucosidase inhibitors (AGIs) are commonly used for controlling postprandial blood glucose, AGIs-induced liver injuries have been reported. However, the relationship between AGIs and liver injuries in advanced chronic kidney disease (CKD) patients remains unexplored. In this nationwide ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Chih-Chin, Wu, Pei-Chen, Wu, Che-Hsiung, Chen, Li-kwang, Chen, Hsi-Hsien, Wu, Mai-Szu, Wu, Vin-Cent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707434/
https://www.ncbi.nlm.nih.gov/pubmed/26751038
http://dx.doi.org/10.1038/srep18996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707434/
https://www.ncbi.nlm.nih.gov/pubmed/26751038
http://dx.doi.org/10.1038/srep18996

Ejemplares similares